시장보고서
상품코드
1274692

세계의 두통성 질환 시장 보고서(2023년)

Headache Disorders Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

두통성 질환 세계 시장은 2022년 40억 7,000만 달러에서 2023년 43억 6,000만 달러에 달하고, 연평균 7.2% 성장할 것으로 예상됩니다. 러시아-우크라이나 전쟁은 적어도 단기적으로는 코로나19 팬데믹으로 인한 세계 경제 회복 가능성을 혼란스럽게 만들었습니다. 이 두 나라 간의 전쟁은 여러 국가에 대한 경제 제재, 상품 가격 상승, 공급망 혼란을 초래하여 상품과 서비스 전반에 걸쳐 인플레이션을 일으켜 세계 많은 시장에 영향을 미쳤습니다. 두통 질환 시장은 2027년까지 연평균 7%의 CAGR로 성장하여 57억 1,000만 달러에 달할 것으로 예상됩니다.

북미가 2022년 두통성 질환 시장에서 가장 규모가 큰 지역이 될 것으로 예상됩니다. 두통성 질환 보고서는 아시아태평양, 서유럽, 중동 및 북유럽, 북미, 남미, 중동 및 아프리카를 대상으로 합니다.

편두통의 유병률 증가는 향후 두통 질환 시장의 성장을 가속할 것으로 예상됩니다. 편두통은 머리 한쪽에 중등도에서 중증의 욱신거림과 맥박이 뛰는 통증이 반복적으로 발생하는 것이 특징인 두통의 일종입니다. 두통성 질환은 편두통을 유발할 수 있는 불쾌한 욱신거리는 통증, 피로감, 메스꺼움 등을 유발하는 신경 장애를 유발할 수 있습니다. 예를 들어, 미국에 본사를 둔 Health Union, LLC의 일부로 만성 질환을 앓고 있는 사람들이 필요로 하는 정보, 연결 및 검증을 제공하는 Migraine.com에 따르면, 2021년에는 미국에서 약 3,900만 명, 세계적으로 10억 명이 편두통을 앓고 있는 것으로 추산됩니다. 따라서 편두통 유병률 증가는 두통 질환 시장 수요를 주도하고 있습니다.

목차

제1장 주요 요약

제2장 두통성 질환 시장 특징

제3장 두통성 질환 시장 동향과 전략

제4장 두통성 질환 시장 - 거시경제 시나리오

  • COVID-19에 의한 두통성 질환 시장에 대한 영향
  • 우크라이나·러시아 전쟁이 두통성 질환 시장에 미치는 영향
  • 고인플레이션이 두통성 질환 시장에 미치는 영향

제5장 두통성 질환 시장 규모와 성장

  • 세계의 두통성 질환 시장 실적, 2017-2022년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 두통성 질환 시장 예측, 2022-2027F, 2032F
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 두통성 질환 시장 세분화

  • 세계의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 편두통
  • 긴장형 두통
  • 빈발 두통
  • 약물 남용에 의한 두통
  • 기타 유형
  • 세계의 두통성 질환 시장, 치료별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 투약
  • 온열 요법
  • 식생활 변경
  • 산소 요법
  • 세계의 두통성 질환 시장, 진단별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 전체 혈구수
  • 두개골 X선
  • 부비강 X선
  • CT 스캔
  • 자기공명영상(MRI)
  • 세계의 두통성 질환 시장, 투여 경로별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 경구
  • 비경구
  • 기타 투여 경로
  • 세계의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 전문 클리닉
  • 홈케어
  • 기타 최종사용자

제7장 두통성 질환 시장 : 지역 및 국가별 분석

  • 세계의 두통성 질환 시장, 지역별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 두통성 질환 시장, 국가별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양의 두통성 질환 시장

  • 아시아태평양의 두통성 질환 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 규제, 규제기관, 주요 단체, 과세액, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 두통성 질환 시장

  • 중국의 두통성 질환 시장 개요
  • 중국의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중국의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 두통성 질환 시장

  • 인도의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 두통성 질환 시장

  • 일본의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 두통성 질환 시장

  • 호주의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 호주의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 두통성 질환 시장

  • 인도네시아의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 두통성 질환 시장

  • 한국의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 두통성 질환 시장

  • 서유럽의 두통성 질환 시장 개요
  • 서유럽의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 두통성 질환 시장

  • 영국의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 영국의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 두통성 질환 시장

  • 독일의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 독일의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 두통성 질환 시장

  • 프랑스의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 두통성 질환 시장

  • 동유럽의 두통성 질환 시장 개요
  • 동유럽의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 두통성 질환 시장

  • 러시아의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 두통성 질환 시장

  • 북미의 두통성 질환 시장 개요
  • 북미의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 북미의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 두통성 질환 시장

  • 미국의 두통성 질환 시장 개요
  • 미국의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 미국의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 두통성 질환 시장

  • 남미의 두통성 질환 시장 개요
  • 남미의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 남미의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 두통성 질환 시장

  • 브라질의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 두통성 질환 시장

  • 중동의 두통성 질환 시장 개요
  • 중동의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중동의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 두통성 질환 시장

  • 아프리카의 두통성 질환 시장 개요
  • 아프리카의 두통성 질환 시장, 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카의 두통성 질환 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제27장 두통성 질환 시장 경쟁 구도와 기업 개요

  • 두통성 질환 시장 경쟁 구도
  • 두통성 질환 시장 기업 개요
    • Teva Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Eli Lilly and Company

제28장 두통성 질환 시장의 주요 인수합병(M&A)

제29장 두통성 질환 시장 전망과 가능성 분석

제30장 부록

LSH 23.05.25

“Headache Disorders Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on headache disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for headache disorders? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The headache disorders market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Migraine; Tension-Type Headache; Cluster Headache; Medication-Overuse Headache; Other Types
  • 2) By Treatment: Medication; Heat Therapy; Diet Changes; Acupuncture; Oxygen Therapy
  • 3) By Diagnosis: Complete Blood Count; Skull X-Rays; Sinus X-Rays; CT Scan; Magnetic Resonance Imaging (MRI)
  • 4) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
  • 5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Hikma Pharmaceuticals PLC; Dr. Reddy's Laboratories Ltd; Novartis AG; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the headache disorders market are Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., and Amgen Inc.

The global headache disorders market is expected to grow from $4.07 billion in 2022 to $4.36 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The headache disorders market is expected to reach $5.71 billion in 2027 at a CAGR of 7%.

The headache disorders market includes revenues earned by entities by providing analgesics, anti-emetics, specific anti-migraine medications, and prophylactic medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Headache disorder is a neurological disorder that is characterized by severe headaches that eoccur on one side of the head, usually around the eye. Headache disorders create a major burden on sufferers, including significant personal pain, decreased quality of life, and financial consequences.

North America was the largest region in the headache disorders market in 2022. The regions covered in headache disorders report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of headache disorders are migraine, tension-type headaches, cluster headaches, medication-overuse headaches, and others. A migraine headache is characterized by intense throbbing pain or a pulsating sensation, typically on one side of the brain. The various treatment involved are medication, heat therapy, diet changes, acupuncture, and oxygen therapy which are diagnosed by complete blood count, skull x-rays, sinus x-rays, ct scans and magnetic resonance imaging (MRI) through oral, parenteral, others and are used for hospitals, specialty clinics, homecare, others.

The increasing prevalence of migraine is expected to propel the growth of the headache disorders market going forward. Migraine refers to a type of headache that is characterized by recurring episodes of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders can cause neurological disorders causing crippling throbbing pain, tiredness, nausea that may cause migraine. For instance, according to Migraine.com, part of US-based Health Union, LLC which provide people living with chronic conditions the information, connection and validation they seek, in 2021, around 39 million people in the United States and 1 billion people worldwide have migraine. Therefore, the increasing prevalence of migraine is driving the demand for the headache disorders market.

Product innovation is a key trend gaining popularity in the headache disorder market. Major companies operating in the headache disorder market are focused on developing innovative products to strengthen their position in the market. For instance, in September 2021, AbbVie, a US-based pharmaceutical company that discovers develops, and markets both biopharmaceuticals and small molecule drugs, launched QULIPTATM (atonement) a prescription medicine for the preventative treatment of episodic migraine in adults. It is uniquely formulated with oral calcitonin gene-related peptide (CGRP) receptor antagonist (giant) in three dose sizes of 10 mg, 30 mg, and 60 mg which are approved by The U.S. Food and Drug Administration (FDA), a US-based department of health.

In May 2022, Man and Science SA, a Belgium-based medical device company, acquired Palion Medical AS for an undisclosed amount. The acquisition of Palion Medical fits well into Man and Science's headache treatment offerings and further drives Man ad Science's ability to provide several therapy solutions to improve patient care. Palion Medical AS a Germany-based clinical-stage medical device company developing a precision injection solution for people suffering from debilitating chronic migraine and cluster headaches.

The countries covered in the headache disorders market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The headache disorders market research report is one of a series of new reports from The Business Research Company that provides headache disorders market statistics, including headache disorders industry global market size, regional shares, competitors with headache disorders market share, detailed headache disorders market segments, market trends, and opportunities, and any further data you may need to thrive in the headache disorders industry. This headache disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Headache Disorders Market Characteristics

3. Headache Disorders Market Trends And Strategies

4. Headache Disorders Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Headache Disorders Market
  • 4.2. Ukraine-Russia War Impact On Headache Disorders Market
  • 4.3. Impact Of High Inflation On Headache Disorders Market

5. Headache Disorders Market Size And Growth

  • 5.1. Global Headache Disorders Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Headache Disorders Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Headache Disorders Market Segmentation

  • 6.1. Global Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Migraine
  • Tension-Type Headache
  • Cluster Headache
  • Medication-Overuse Headache
  • Other Types
  • 6.2. Global Headache Disorders Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Medication
  • Heat Therapy
  • Diet Changes
  • Acupuncture
  • Oxygen Therapy
  • 6.3. Global Headache Disorders Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Complete Blood Count
  • Skull X-Rays
  • Sinus X-Rays
  • CT Scan
  • Magnetic Resonance Imaging (MRI)
  • 6.4. Global Headache Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administrations
  • 6.5. Global Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Headache Disorders Market Regional And Country Analysis

  • 7.1. Global Headache Disorders Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Headache Disorders Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Headache Disorders Market

  • 8.1. Asia-Pacific Headache Disorders Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Headache Disorders Market

  • 9.1. China Headache Disorders Market Overview
  • 9.2. China Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Headache Disorders Market

  • 10.1. India Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Headache Disorders Market

  • 11.1. Japan Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Headache Disorders Market

  • 12.1. Australia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Headache Disorders Market

  • 13.1. Indonesia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Headache Disorders Market

  • 14.1. South Korea Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Headache Disorders Market

  • 15.1. Western Europe Headache Disorders Market Overview
  • 15.2. Western Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Headache Disorders Market

  • 16.1. UK Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Headache Disorders Market

  • 17.1. Germany Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Headache Disorders Market

  • 18.1. France Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Headache Disorders Market

  • 19.1. Eastern Europe Headache Disorders Market Overview
  • 19.2. Eastern Europe Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Headache Disorders Market

  • 20.1. Russia Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Headache Disorders Market

  • 21.1. North America Headache Disorders Market Overview
  • 21.2. North America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Headache Disorders Market

  • 22.1. USA Headache Disorders Market Overview
  • 22.2. USA Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Headache Disorders Market

  • 23.1. South America Headache Disorders Market Overview
  • 23.2. South America Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Headache Disorders Market

  • 24.1. Brazil Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Headache Disorders Market

  • 25.1. Middle East Headache Disorders Market Overview
  • 25.2. Middle East Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Headache Disorders Market

  • 26.1. Africa Headache Disorders Market Overview
  • 26.2. Africa Headache Disorders Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Headache Disorders Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Headache Disorders Market Competitive Landscape And Company Profiles

  • 27.1. Headache Disorders Market Competitive Landscape
  • 27.2. Headache Disorders Market Company Profiles
    • 27.2.1. Teva Pharmaceutical Industries Ltd.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Hikma Pharmaceuticals PLC
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dr. Reddy's Laboratories Ltd
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novartis AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Eli Lilly and Company
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Headache Disorders Market

29. Headache Disorders Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제